Target intelligence / Profile preview

NADH:ubiquinone oxidoreductase subunit B10 (NDUFB10)

Target
NDUFB10
Molecular classification
Enzyme, Mitochondrial respiratory chain complex subunit
01

Overview

NADH:ubiquinone oxidoreductase subunit B10 (NDUFB10) is a protein-coding gene of the mitochondrial respiratory chain complex I, the first and largest enzyme complex in the mitochondrial electron transport chain. NDUFB10 is an accessory subunit, required for the assembly and stability of complex I, which catalyzes electron flow from NADH to ubiquinone, coupled with proton translocation across the inner mitochondrial membrane, ultimately driving ATP synthesis. Mutations or dysfunction in NDUFB10 can lead to mitochondrial complex I deficiency, a group of severe metabolic disorders with neuromuscular and multisystem involvement. NDUFB10 is not a direct drug target but is a subunit of the clinically significant complex I enzyme, which is targeted by inhibitors such as piericidin A and rotenone. Disease involvement includes neurodegenerative and metabolic conditions. Complex I inhibitors pose risks of mitochondrial toxicity and functional impairment

Other names
NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 10CI-PDSWPDSWComplex I-PDSWNADH-ubiquinone oxidoreductase PDSW subunitcomplex I PDSW subunitMC1DN35
02

Mechanism of action

Competitive inhibition of the ubiquinone-binding site (e.g., piericidin A mimics ubiquinone and blocks electron transfer) Noncompetitive inhibition (other inhibitors may block electron transfer or alter conformation)

03

Biological functions

Mitochondrial electron transportNADH to ubiquinone electron transferATP synthesis (proton motive force-driven)Assembly and function of respiratory chain complex I
04

Disease associations

Mitochondrial complex I deficiencyNeurodegenerative disease (e.g., Parkinson’s disease)Metabolic disorderCardiovascular disease (ischemia/reperfusion injury)
05

Safety considerations

Inhibition or dysfunction of NDUFB10/complex I leads to potential cellular energy failure, lactic acidosis, neuromuscular degenerationMitochondrial toxicity (off-target drug effects on respiration)Increased risk for metabolic and neurological symptoms in susceptible patients
06

Interacting drugs

Piericidin A (complex I inhibitor)

2 more in the full profile.

07

Biomarkers

Complex I activity in tissues or blood (for mitochondrial function/disease diagnosis)NDUFB10 mutation or expression status (for mitochondrial complex I deficiency)

Beyond the preview

Go deeper on NADH:ubiquinone oxidoreductase subunit B10 (NDUFB10).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on NADH:ubiquinone oxidoreductase subunit B10 (NDUFB10).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call